BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Arena Pharmaceuticals, Inc. (NQ: ARNA)
6.160 USD  -0.180 (-2.84%)
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(ARNA) Community Analysis from
April 23, 2014
(Stock Blog Hub, 10/23/12)
Arena Pharmaceuticals, Inc. (ARNA) recently initiated a phase I multiple dose study with APD811, which is being developed for the treatment of pulmonary arterial hypertension...(read more)
by Kelly Jamrozy The weight loss industry is a booming business, but one of the places it often struggles is with prescription weight loss drugs. This is...(read more)
Courtesy of Benzinga. Americans have gotten so irreversibly out of shape that the markets think we are going to need a [...]
Arena Pharmaceuticals (ARNA) Company Overview

There is no analysis for ARNA yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here